DERMTECH OPERATIONS, INC.
SAN DIEGO, CA

DermTech Operations, Inc., formerly known as DermTech, Inc., is a pioneering leader in molecular dermatology with its headquarters located at 12340 El Camino Real, San Diego, CA. The company distinguishes itself through the development and marketing of innovative products that enhance the early detection of skin cancers, evaluate inflammatory conditions, and support personalized drug treatments for dermal diseases. DermTech leverages non-invasive adhesive patches to gather skin biopsy samples as opposed to traditional scalpel methods, exemplifying its commitment to modernizing dermatology practices. Operating under a CLIA licensed laboratory at its La Jolla, CA headquarters, DermTech employs precision medicine approaches that aid clinicians with precise and objective insights, thus improving patient care while diminishing costs. It also collaborates with pharmaceutical companies to promote the development of targeted therapies. Under its leadership, key individuals like John Dobak, MD, bring extensive experience from founding several venture-backed life science firms in San Diego. Dr. Yao contributes over 16 years of expertise in biotech product development, having previously served at leading roles in Nexogen and other notable companies. The company's team includes Burkhard Jansen, MD, a respected melanoma expert with substantial academia and industry experience. The commercial operations are led by Sarah Dion, who brings profound insight from her successful tenure at LABS Inc., where she oversaw significant sales growth. Moreover, James Rock enriches DermTech as Vice President of Clinical Operations and Research Contracts with over 15 years in drug development and business affairs. Together, this team drives DermTech's mission to revolutionize dermatological care and therapy through cutting-edge technology and robust product offerings.